Susan Macdonald, MD
Urology · Hershey, PANPI 1992093488
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $24,600 of the $39,970 with a category attached, or 61.5%. Boston Scientific accounts for 98.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $24,636 and has fallen 91.4% since, to $2,129 in 2025. Among urology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 92 payments — averaging $434.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$39K
- KARL Storz Endoscopy-america$139
- Astellas Pharma US Inc$133
- Urogen Pharma, Inc.$127
- Cook Medical LLC$117
- Photocure Inc$77
- plus $182 from 6 others
Across 1 payment — averaging $10,650 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Uromedica, Incorporated$11K
What the payments were for
- Consulting fees$8,15020%
- Speaking & faculty fees$24,60062%
- Travel & lodging$4,10210%
- Food & beverage$3,1188%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 77 | $39,195 |
| KARL Storz Endoscopy-america | 2 | $139 |
| Astellas Pharma US Inc | 2 | $133 |
| Urogen Pharma, Inc. | 2 | $127 |
| Cook Medical LLC | 1 | $117 |
| Photocure Inc | 1 | $77 |
| Endo Pharmaceuticals Inc. | 1 | $53 |
| Coloplast | 2 | $40 |
| AbbVie | 1 | $30 |
| Johnson & Johnson | 1 | $24 |
| Baxter Healthcare | 1 | $22 |
| LSI Solutions Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TACTRA$17,908
- AMS$7,080
- GENERAL ERECTILE DYSFUNCTION$1,359
- AMS AMBICOR$750
- AMS 700$528
- GENERAL - THERAPIES$138
- rezum Generator$133
- N/A$123
- Cook$117
How this compares
$39,970 in reported general payments places this provider in the 90th percentile of 596 urology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 24 | $201 |
| Paroxetine Hcl | 14 | $152 |
| Finasteride | 25 | $64 |
Paid to pharmacies, not to this prescriber.
Other urology in Hershey
- John AndersonBethlehem$2.1M
- Demetrius BagleyPhiladelphia$739K
- Paul SieberLancaster$631K
- Daniel EunPhiladelphia$226K
- Leonard GomellaPhiladelphia$190K
- Anthony DimatteoButler$189K
- Angelo BaccalaAllentown$166K
- Phillip GinsbergPhiladelphia$145K
- Edouard TrabulsiPhiladelphia$137K
- Siobhan HartiganPhiladelphia$121K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.